SOHO Highlights: State of the Art and Next Questions | VuMedi

SOHO Highlights: State of the Art and Next Questions

SOHO Highlights: State of the Art and Next Questions

SOHO Highlights: State of the Art and Next Questions

CLL: State of the Art and Next Questions

By SOHO Highlights: State of the Art and Next Questions FEATURING Nitin Jain

By SOHO Highlights: State of the Art and Next Questions FEATURING Nitin Jain

247 views

March 25, 2024

Progress & Therapies in CLL: From Chemotherapy to Targeted Treatments

00:00

First-line CLL Treatment & RESONATE-2: Ibrutinib vs Chlorambucil

01:06

Frontline Therapies: Acalabrutinib Efficacy & Treatment Preferences

02:31

Zanubrutinib Approval & PFS Evidence from SEQUOIA Trial

03:40

Time-Limited Approaches & EHA 2023 Update for Venetoclax with Obinutuzumab

04:21

Considering Targeted Therapies & Ongoing Research for Frontline CLL

06:04

Relapsed/Refractory CLL: Sequencing Scenarios & Therapies

16:25

Selecting BTK Inhibitors for Relapsed CLL & Data from ELEVATE-RR and ALPINE Trials

18:28

Emerging Agents for CLL: Pirtobrutinib Efficacy & CAR-T Therapies

20:13

Comments 0

Login to view comments. Click here to Login